BioPharma Credit PLC (LON:BPCR)

BioPharma Credit Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	68.71	12.59	5.62	135.05	120.53	94.71
Cash & Short-Term Investments	68.71	12.59	5.62	135.05	120.53	94.71
Cash Growth	1496.05%	123.97%	-95.84%	12.05%	27.26%	-51.00%
Accounts Receivable	16.71	53.46	31.71	20.23	19.73	9.59
Other Receivables	-	0.14	0.08	0.09	0.11	0.42
Receivables	16.71	53.6	31.8	20.32	19.84	10.01
Total Current Assets	85.42	66.19	37.42	155.37	140.37	104.72
Long-Term Investments	1,057	1,102	1,162	1,201	1,224	1,266
Total Assets	1,142	1,168	1,200	1,357	1,364	1,371

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accrued Expenses	-	17.56	16.94	15.87	24.35	6.34
Other Current Liabilities	-	-	0.95	-	1.95	-
Total Current Liabilities	3.23	17.56	17.88	15.87	26.3	6.34
Long-Term Unearned Revenue	-	-	0.06	-	0.26	0.56
Total Liabilities	3.23	17.56	17.94	15.87	26.56	6.9

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	13.74	13.74	13.74	13.74	13.74	13.74
Additional Paid-In Capital	607.13	607.13	607.13	607.13	607.13	607.13
Retained Earnings	516.42	530	560.81	720	716.59	742.85
Shareholders' Equity	1,139	1,151	1,182	1,341	1,337	1,364
Total Liabilities & Equity	1,142	1,168	1,200	1,357	1,364	1,371

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Cash (Debt)	68.71	12.59	5.62	135.05	120.53	94.71
Net Cash Growth	1496.05%	123.97%	-95.84%	12.05%	27.26%	-51.00%
Net Cash Per Share	0.06	0.01	0.00	0.10	0.09	0.07
Filing Date Shares Outstanding	1,127	1,129	1,140	1,254	1,319	1,374
Total Common Shares Outstanding	1,127	1,129	1,186	1,303	1,319	1,374
Working Capital	82.19	48.63	19.53	139.5	114.06	98.38
Book Value Per Share	1.01	1.02	1.00	1.03	1.01	0.99
Tangible Book Value	1,139	1,151	1,182	1,341	1,337	1,364
Tangible Book Value Per Share	1.01	1.02	1.00	1.03	1.01	0.99

Data Source: S&P Global Market Intelligence Last updated: Mar 24, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Sep 25, 2026

Data Sources Report a data error